A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence
Year: 2015
Type: review
Source: Drugs & Aging
Authors: Jacob S. Buckley, Shelley R. Salpeter
Institutions: Brown University, Stanford Medicine, Stanford University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: dementia, mild cognitive impairment, cholinesterase inhibitors, memantine, Alzheimer's disease, dementia with Lewy bodies, vascular dementia, treatment efficacy, adverse effects, weight loss, syncope, debility, elderly patients, risk-benefit assessment, cognitive function, functional outcome, treatment duration, dose-dependent side effects, long-term treatment outcomes
Open Access status: closed
OpenAlex ID: W1720436125
